HR+, HER2-, Advanced Breast Cancer

Explore clinical trials studying HR+, HER2-, Advanced Breast Cancer. Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

HR+, HER2-, Advanced Breast Cancer trial results

Recruiting

NCT06998407

Conditions: HR+, HER2-, Advanced Breast Cancer, HR+/HER2- Breast Cancer
Locations: Avenzo Therapeutics Recruiting Site Los Angeles, California, United States

Avenzo Therapeutics Recruiting Site Los Angeles, California, United States

Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States

Avenzo Therapeutics Recruiting Site Orlando, Florida, United States

View all 15 locations

Recruiting

NCT05867251

Conditions: Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +35 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Florida Cancer Specialists Sarasota, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Perlmutter Cancer Center at NYU Langone Hospital - Long Island Mineola, New York, United States

View all 13 locations

Recruiting

NCT06827613

Conditions: HR+, HER2-, Advanced Breast Cancer, Triple Negative Locally Advanced Non-resectable Breast Cancer
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

UCLA Health Los Angeles, California, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

Active, Not Recruiting

NCT07018427

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Peking University Cancer Hospital & Institute Beijing, Beijing Municipality, China